Skip to main content

Advertisement

Log in

Master Protocol for squamous cell lung cancer readies for launch

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Change history

  • 29 May 2014

    In the version of this article initially published, Genentech's compound Taselisib was incorrectly labeled as Pictilisib in Table 1. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, J. Master Protocol for squamous cell lung cancer readies for launch. Nat Biotechnol 32, 116–117 (2014). https://doi.org/10.1038/nbt0214-116b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0214-116b

  • Springer Nature America, Inc.

Navigation